Mild cognitive impairment as a diagnostic entity.
R C Petersen
https://pubmed.ncbi.nlm.nih.gov/15324362Actively Recruiting
Led by The University of Hong Kong · Updated on 2025-12-03
62
Participants Needed
1
Research Sites
13 weeks
Total Duration
Researchers are investigating a new approach to help people living with mild cognitive impairment (MCI) who also have hearing loss. The study explores combining auditory training with cognitive training to improve both hearing and cognitive abilities. This integrated care approach includes strategies like goal-setting, peer support, and involvement of family members to enhance communication and social interaction. The study is a pilot mixed-method trial involving 62 participants with MCI and hearing impairment, recruited from community centers. The study compares two groups: one receiving the 12-week Empowerment Network for Auditory-Cognitive Training (ENACT) program and a usual care group. The ENACT program has three phases: goal-oriented health counseling led by a nurse in the first two weeks, peer-assisted group auditory-cognitive training sessions in weeks three to eight, and family-engaged active communication training in weeks nine to twelve. The usual care group participates in social activities but does not receive cognitive or auditory training during the study. Participants will be assessed before starting the study and again at weeks 12 and 18. Assessments include tests of cognitive function such as the Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog), digit span tests, and Trail-Making Tests. Hearing function and perceived benefits of auditory training, as well as quality of life measures, will also be evaluated. After the intervention, interviews with participants, their family caregivers, and peer health coaches will explore their experiences. The study aims to understand the feasibility and potential benefits of this integrated training approach.
CONDITIONS
ENACT Program on Auditory Perception and Function, Cognitive Function and Health-related Quality of Life
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 weeks
Participants receive the 12-week ENACT Program, which includes three phases: goal-oriented health counseling, peer-assisted group-based auditory-cognitive training, and family engaged active-communication training, all led by a nurse with support from trained peers and family caregivers to improve hearing and cognitive function.
Multiple visits including nurse consultations, peer group sessions, telephone and online support, and family training sessions over 12 weeks
Duration - 6 weeks
Participants undergo outcome evaluations and monitoring at 12 and 18 weeks after starting the intervention to assess hearing function, cognitive function, and quality of life.
2 visits (in-person) at 12th and 18th week after baseline
Total: 1 location
1
The University of Hong Kong
Hong Kong, Hong Kong
Actively Recruiting
S
SAU FUNG DORIS YU, PhD
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
R C Petersen
https://pubmed.ncbi.nlm.nih.gov/15324362Ariane Laplante-Lévesque, Louise Hickson, Linda Worrall
https://pubmed.ncbi.nlm.nih.gov/20056812Lillemor R M Hallberg, Ulrika Hallberg, Sophia E Kramer
https://pubmed.ncbi.nlm.nih.gov/17852289G M Sprinzl, H Riechelmann
https://pubmed.ncbi.nlm.nih.gov/20090297Lindsey E Jorgensen, Jessica J Messersmith
https://pubmed.ncbi.nlm.nih.gov/27516716Nicola E Gallagher, Jayne V Woodside
https://pubmed.ncbi.nlm.nih.gov/29664724Huili Zheng, Lena L N Wong, Louise Hickson
https://pubmed.ncbi.nlm.nih.gov/35997572Magda Bucholc, Sarah Bauermeister, Daman Kaur...
https://pubmed.ncbi.nlm.nih.gov/35229022Piers Dawes, Lucas Wolski, Ines Himmelsbach...
https://pubmed.ncbi.nlm.nih.gov/30244688Lele Chen, Renlai Zhou
https://pubmed.ncbi.nlm.nih.gov/33036703